Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-31
1998-06-09
Lambkin, Deborah
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514393, 514418, 514387, 514629, 548165, 548169, 548171, 5483064, 548480, 564155, 564158, 564215, 564218, A61K 31425, A61K 3116, C07D27762, C07C23302
Patent
active
057634653
ABSTRACT:
There are disclosed compounds of formula I,
REFERENCES:
patent: 3996383 (1976-12-01), Colella et al.
Weinstock et al, "Synthesis and evaluation of non-catechol D-1 and D-2 dopamine receptor agonists: benzimidazol-2-one, benzoxazol-2-one, and the highly potent: benzothiazol-2-one 7-ethylamines"CA 107:77705, 1987.
DeMarinis et al, "Syntheses and in vitro evaluation of 4-2-aminoethyl-23H0-indolones and related compounds as peripheral prejunctional dopamine receptor agonists", CA 105:6379, 1986.
Dixon et al, "Phenylethylamines and compositions containing them", CA 104:5631, 1986.
Colella et al (l) "N, 1973.
Jack et al, "Hypotensive phenylethylamine, derivatives", CA 75:35408, 1971.
CA 96:6373C, 1983.
Bonnert Roger V.
Brown Roger C.
Cheshire David R.
Dixon John
Ince Francis
Astra Pharmaceuticals Limited
Lambkin Deborah
LandOfFree
7-(2-aminoethyl) benzothiazolones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-(2-aminoethyl) benzothiazolones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-(2-aminoethyl) benzothiazolones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2199541